AMC
AMC Entertainment Holdings, Inc.
AMC has the edge over CRTO overall, supported by stronger fundamentals and stronger modeled upside.
CRTO
Criteo S.A.
CRTO offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
CRTO Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Healthy | |
| Unavailable |
CRTO's cash flow is currently healthy, and its profitability is stable, but its revenue is under pressure. There isn't enough data to rate its balance sheet.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
CRTO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.9x | $17.43 | — |
| Cheap | 8.6x | $11.90 | -32% |
| Current | 13x | $17.43 | — |
| Fair | 19x | $26.52 | +52% |
| Expensive | 33x | $45.77 | +163% |
Historical ranges are pointers, not guarantees.
CRTO's PE is in its fair range at 13x. If earnings grow as analysts expect, today's price would be 4.9x next year's earnings, in its cheap range.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
AMC has the edge over CRTO on the outlook, with more favorable revenue expectations.
CRTO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect CRTO's earnings to grow and its profitability to improve, with its revenue holding steady.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
AMC lost $0.40 per share over the past year, a smaller loss than the year before.
CRTO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.59 | +160% |
| Q3 2026 | $1.38 | -53% |
| Q2 2026 | $1.97 | -17% |
| Q1 2026 | $2.14 | -12% |
| Q4 2025 | $2.65 | +39% |
| Q3 2025 | $2.96 | +74% |
| Q2 2025 | $2.37 | +39% |
| Q1 2025 | $2.44 | +103% |
| Q4 2024 | $1.90 | +116% |
CRTO has the edge over AMC on earnings quality, reporting a profit while its opponent remains loss making.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC has the edge over CRTO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC has the edge over CRTO on profitability, with a higher operating margin.
CRTO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $416.5M | -11% |
| Q2 2026 | $428M | -11% |
| Q1 2026 | $424.6M | -5.9% |
| Q4 2025 | $541.1M | -2.2% |
| Q3 2025 | $469.7M | +2.3% |
| Q2 2025 | $482.7M | +2.4% |
| Q1 2025 | $451.4M | +0.3% |
| Q4 2024 | $553M | -2.3% |
CRTO's revenue has slid since its 2020 peak: $416M last quarter, down 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5% | -6 points |
| Q2 2026 | 3.5% | -2.8 points |
| Q1 2026 | 2.5% | -8.2 points |
| Q4 2025 | 13% | -3.7 points |
| Q3 2025 | 11% | +8.9 points |
| Q2 2025 | 6.3% | -1.5 points |
| Q1 2025 | 11% | +8.4 points |
| Q4 2024 | 17% | +1.5 points |
CRTO's operating margin was 5% last quarter, down 6 points from the same quarter a year ago.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC has the edge over CRTO on cash flow, with more consistent year-over-year improvement.
CRTO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.1M | -68% |
| Q2 2026 | -$37.9M | -$1.3M |
| Q1 2026 | $15.4M | -66% |
| Q3 2025 | $66.6M | +16% |
| Q2 2025 | -$36.6M | -313% |
| Q1 2025 | $45.3M | +223% |
| Q3 2024 | $57.5M | +193% |
| Q2 2024 | $17.2M | +1194% |
CRTO still generates free cash flow, though less than at its 2023 peak: $132M over the past year.
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC's net debt is about 4.0 years of its operating earnings (EBITDA), down from 12 years a year ago.
CRTO Net Leverage
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
CRTO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.3 | Neutral |
| Stochastic | 31.1 | Neutral |
CRTO's weekly RSI is 50 (neutral) and its Stochastic is 31 (neutral).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
CRTO PE vs Communication Services Sector
| Metric | CRTO | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 16x | 23% below |
| PE % | 39 | 26 | 13 pts above |
CRTO is trading at 13x earnings, a 23% discount to the Communication Services sector's median of 16x.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has the edge over CRTO on trend strength, trading above more of its moving averages.
CRTO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.6 | 12% above |
| 20 week MA | $17.8 | 1.9% below |
| 50 week MA | $18.3 | 4.5% below |
| 100 week MA | $23.5 | 26% below |
| 200 week MA | $28.7 | 39% below |
CRTO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 39% below its 200-week average.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over CRTO on returns for 2026, with the stronger performance.
CRTO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.2 | $20.8 | +21% |
| 2021 | $20.8 | $37.1 | +78% |
| 2022 | $37.1 | $26.0 | -30% |
| 2023 | $26.0 | $25.3 | -2.5% |
| 2024 | $25.3 | $40.5 | +60% |
| 2025 | $40.5 | $20.0 | -51% |
| 2026 YTD | $20.0 | $17.4 | -13% |
CRTO has finished lower in three of the last six years. It's down 13% so far in 2026.